Neurostimulation as a Method of Treatment and a Preventive Measure in Canine Drug-Resistant Epilepsy: Current State and Future Prospects - PubMed
- ️Sat Jan 01 2022
Review
Neurostimulation as a Method of Treatment and a Preventive Measure in Canine Drug-Resistant Epilepsy: Current State and Future Prospects
Marta Nowakowska et al. Front Vet Sci. 2022.
Abstract
Modulation of neuronal activity for seizure control using various methods of neurostimulation is a rapidly developing field in epileptology, especially in treatment of refractory epilepsy. Promising results in human clinical practice, such as diminished seizure burden, reduced incidence of sudden unexplained death in epilepsy, and improved quality of life has brought neurostimulation into the focus of veterinary medicine as a therapeutic option. This article provides a comprehensive review of available neurostimulation methods for seizure management in drug-resistant epilepsy in canine patients. Recent progress in non-invasive modalities, such as repetitive transcranial magnetic stimulation and transcutaneous vagus nerve stimulation is highlighted. We further discuss potential future advances and their plausible application as means for preventing epileptogenesis in dogs.
Keywords: deep brain stimulation; dogs; drug-resistant epilepsy; epileptogenesis; seizure; transcranial magnetic stimulation; vagus nerve stimulation.
Copyright © 2022 Nowakowska, Üçal, Charalambous, Bhatti, Denison, Meller, Worrell, Potschka and Volk.
Conflict of interest statement
GW has rights to receive future royalties from the licensing of technology to Cadence Neuroscience Inc, and has received research support from Medtronic, LivaNova, and was previously on the scientific advisory board of NeuroPace Inc. HV served as paid consultant in the field of epilepsy for Boehringer Ingelheim, CEVA animal health, Nestle Purina and served as contract researcher for: Nestle Purina, Desitin Pharma and Boehringer Ingelheim. HP received funding for consulting, talks and research collaborations from Eisai, Zogenix, Elanco, Roche, Exeed Epidarex, Arvelle and MSD. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

A demonstrative illustration of assembly of invasive VNS (A) and DBS (B) in a dog. VNS electrodes are mostly wrapped around the cervical portion of left vagus nerve, whereas DBS electrodes are usually placed in thalamic nuclei. Wires and a controlling device are usually located in a dorsal cervical region. Created with
BioRender.com.

Advantages and challenges related to each of the neurostimulation methods used in veterinary medicine to treat drug-resistant epilepsy in dogs. VNS, vagus nerve stimulation; DBS, deep brain stimulation; TMS, transcranial magnetic stimulation.

Future perspectives for neurostimulation in drug-resistant epilepsy in dogs. Long-term stimulation might lead to disease modifying effects through alterations in neuronal networks (upper part) or anti-inflammatory effects (middle part), which might be utilized to curb epileptogenic processes. Use of repetitive transcranial magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS) might both be considered non-invasive strategies for long-term stimulation in patients not eligible for surgery.
Similar articles
-
Effect of neurostimulation on cognition and mood in refractory epilepsy.
Chan AY, Rolston JD, Rao VR, Chang EF. Chan AY, et al. Epilepsia Open. 2018 Feb 13;3(1):18-29. doi: 10.1002/epi4.12100. eCollection 2018 Mar. Epilepsia Open. 2018. PMID: 29588984 Free PMC article. Review.
-
Neurostimulation as a promising epilepsy therapy.
Lin Y, Wang Y. Lin Y, et al. Epilepsia Open. 2017 Aug 23;2(4):371-387. doi: 10.1002/epi4.12070. eCollection 2017 Dec. Epilepsia Open. 2017. PMID: 29588969 Free PMC article. Review.
-
Boon P, De Cock E, Mertens A, Trinka E. Boon P, et al. Curr Opin Neurol. 2018 Apr;31(2):198-210. doi: 10.1097/WCO.0000000000000534. Curr Opin Neurol. 2018. PMID: 29493559
-
Vagus nerve stimulation for conservative therapy-refractive epilepsy and depression.
Möbius H, Welkoborsky HJ. Möbius H, et al. Laryngorhinootologie. 2022 May;101(S 01):S114-S143. doi: 10.1055/a-1660-5591. Epub 2022 May 23. Laryngorhinootologie. 2022. PMID: 35605616 English, German.
-
A Review of Neurostimulation for Epilepsy in Pediatrics.
Starnes K, Miller K, Wong-Kisiel L, Lundstrom BN. Starnes K, et al. Brain Sci. 2019 Oct 18;9(10):283. doi: 10.3390/brainsci9100283. Brain Sci. 2019. PMID: 31635298 Free PMC article. Review.
Cited by
-
Diffusion tensor-based analysis of white matter in dogs with idiopathic epilepsy.
Beckmann KM, Wang-Leandro A, Steffen F, Richter H, Dennler M, Bektas R, Carrera I, Haller S. Beckmann KM, et al. Front Vet Sci. 2023 Dec 18;10:1325521. doi: 10.3389/fvets.2023.1325521. eCollection 2023. Front Vet Sci. 2023. PMID: 38192722 Free PMC article.
-
Despa A, Musteata M, Solcan G. Despa A, et al. Vet Sci. 2024 Sep 4;11(9):408. doi: 10.3390/vetsci11090408. Vet Sci. 2024. PMID: 39330787 Free PMC article.
-
Charalambous M, Muñana K, Patterson EE, Platt SR, Volk HA. Charalambous M, et al. J Vet Intern Med. 2024 Jan-Feb;38(1):19-40. doi: 10.1111/jvim.16928. Epub 2023 Nov 3. J Vet Intern Med. 2024. PMID: 37921621 Free PMC article.
References
-
- Hulsmeyer VI, Fischer A, Mandigers PJ, DeRisio L, Berendt M, Rusbridge C, et al. . International Veterinary Epilepsy Task Force's current understanding of idiopathic epilepsy of genetic or suspected genetic origin in purebred dogs. BMC Vet Res. (2015) 11:175. 10.1186/s12917-015-0463-0 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources